DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Van Cutsem E, Lang I, D’haens G et al.
KRAS status and efficacy in the first-line treatment of patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI with or without cetuximab: The CRYSTAL experience.
J Clin Oncol 2008;
26 (abstr 2)
We do not assume any responsibility for the contents of the web pages of other providers.